“Pretreatment with loading-dose UFH at FMC could be considered to reduce the inherent delay from FMC to cathlab in the current regional networks, thereby attenuating myocardial injury and improving clinical prognosis in patients with STEMI.”
Gorog et al. (Mon,) studied this question.